Global Medical REIT (GMRE) Expected to Announce Earnings on Wednesday

Global Medical REIT (NYSE:GMRE) will likely be releasing its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $1.02 per share and revenue of $37.4420 million for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 26, 2026 at 9:00 AM ET.

Global Medical REIT Price Performance

Shares of NYSE GMRE opened at $36.59 on Wednesday. The company has a debt-to-equity ratio of 1.65, a current ratio of 0.52 and a quick ratio of 0.52. Global Medical REIT has a 1-year low of $29.05 and a 1-year high of $45.75. The company has a market capitalization of $490.54 million, a price-to-earnings ratio of -146.35 and a beta of 1.18. The business has a 50-day moving average of $35.11 and a 200-day moving average of $34.25.

Global Medical REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Shareholders of record on Friday, December 19th were given a $0.75 dividend. The ex-dividend date of this dividend was Friday, December 19th. This represents a $3.00 annualized dividend and a yield of 8.2%. Global Medical REIT’s dividend payout ratio (DPR) is -1,200.00%.

Hedge Funds Weigh In On Global Medical REIT

Several large investors have recently modified their holdings of the stock. Caitong International Asset Management Co. Ltd raised its stake in Global Medical REIT by 1,001.4% during the third quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company’s stock valued at $27,000 after buying an additional 721 shares in the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Global Medical REIT by 70.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,379 shares of the company’s stock valued at $51,000 after acquiring an additional 3,046 shares during the last quarter. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Global Medical REIT during the 2nd quarter valued at approximately $78,000. Virtus Advisers LLC lifted its stake in Global Medical REIT by 46.5% during the fourth quarter. Virtus Advisers LLC now owns 2,418 shares of the company’s stock worth $82,000 after purchasing an additional 768 shares during the last quarter. Finally, State of Wyoming lifted its stake in Global Medical REIT by 71.3% during the second quarter. State of Wyoming now owns 12,656 shares of the company’s stock worth $88,000 after purchasing an additional 5,266 shares during the last quarter. Institutional investors own 57.52% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Wall Street Zen cut shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Weiss Ratings raised shares of Global Medical REIT from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, January 21st. Finally, Robert W. Baird decreased their price objective on shares of Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $42.00.

About Global Medical REIT

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.